Click here to subscribe to Biomedical Materials and immediately access all its archives
Click here to review the contents of the January 2007 issue of Biomedical Materials and download it online
Issue: January 2007, page: 10
TISSUE ENGINEERING - Pervasis is set to go ahead with Phase II trials of cell-based repair gel, following good results from initial trials
The safety results from the Phase I trials of the trademarked Vascugel cell-based gel to repair arteries are sufficiently good for the developer of the gel, Pervasis Therapeutics, to be able to go ahead with Phase II trials of the product in 2007.
